JDD Corner

JDD August 2023 Issue Highlights | Special Focus: Psoriasis

With a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk:

Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer comprehensive direction on the topical treatment of psoriasis.

Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians offers valuable insights that help differentiate the appearance and symptoms of pediatric psoriasis from other prevalent pediatric skin conditions.

In Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis: Week 28 Interim Analysis of a Phase 4 Study, authors share their assessments of significant findings of 52 patients.

A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults describes the preclinical and clinical studies demonstrating the efficacy and safety of tapinarof, its place in therapy, and its relevance to patient care. 

Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque Psoriasis shows that adjunctive use of this ointment enhanced patient response to tildrakizumab. 

Psoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis discusses the need to develop a more robust body of evidence on skincare for psoriasis to influence clinical practice in a meaningful way.

Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis presents unique biological outcomes that manifest clinically as therapeutic disease control for patients with psoriasis.

Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review meticulously analyzes 30 articles, comprising observations from 634 patients, to assess treatment responses and adverse effects thoroughly.  

Off-Label Use of Baricitinib in Dermatology presents the available literature on this topic and will be of interest to practitioners in the field. 

Review of Superficial Cryotherapy for the Treatment of Alopecia Areata presents a thorough summary of studies evaluating patient populations, experimental groups, their assessments, and their results.

Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients ≥ 12 Years of Age With Acne Vulgaris analyzes the favorable results of this 600-patient study.

Dermatology in Contemporary Times: Building Awareness of Social Media’s Association With Adolescent Skin Disease and Mental Health highlights the crucial responsibilities clinicians bear in effectively communicating realistic outcome expectations of cosmetic procedures to their younger patients.

Verrucous Psoriasis: Rare Variant and Novel Treatment presents the findings of a successful treatment for this condition.

Talquetamab-Induced Grover’s Disease discusses possible effects related to treating patients with GD.  

Juvenile Pemphigus Foliaceus in a Patient With Psoriasis Receiving Narrow-Band Ultraviolet-B: Successful Treatment With Rituximab shares the results of this uncommon condition.

Rethinking the Inflammatory Balance in Psoriasis and Atherosclerosis examines the convergence of the pathophysiology of psoriasis and atherosclerosis.

In No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United Statesthe authors conducted a comparative analysis of biologic utilization in adult and pediatric psoriasis patients from various racial backgrounds in the United States.  

The Patient-Physician Relationship and Adherence: Observations From a Clinical Study expands on the limited literature assessing how PPR affects adherence in dermatology.

Antimalarials Are Not Effective as Pre-Exposure Prophylaxis for Covid-19: A Retrospective Matched Control Study demonstrates that antimalarials did not significantly prevent SARS-CoV-2 infection in patients.

Extra, Extra, Treatment Approaches for Extramammary Paget Disease comments on the growing evidence that MMS presents favorable patient outcomes with improved relapse-free survival.

Find more JDD Issue Highlights here